Accelerated epigenetic aging in women with emotionally unstable personality disorder and a history of suicide attempts.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
22 02 2023
Historique:
received: 29 01 2023
accepted: 13 02 2023
revised: 07 02 2023
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 25 2 2023
Statut: epublish

Résumé

Emotional unstable personality disorder (EUPD; previously borderline personality disorder, BPD) is associated with excess natural-cause mortality, comorbid medical conditions, poor health habits and stress related epigenomic alterations. Previous studies demonstrated that GrimAge - a state-of-the-art epigenetic age (EA) estimator - strongly predicts mortality risk and physiological dysregulation. Herein, we utilize the GrimAge algorithm to investigate whether women with EUPD and a history of recent suicide attempts exhibit EA acceleration (EAA) in comparison to healthy controls. Genome-wide methylation patterns were measured using the Illumina Infinum Methylation Epic BeadChip in whole blood from 97 EUPD patients and 32 healthy controls. The control group was significantly older (p < 0.0001) and reported lesser exposure to violent behavior in both youth and adulthood (p < 0.0001). Groups were otherwise comparable regarding gender, BMI, or tobacco usage (p > 0.05). EA estimator DNAmGrimAge exceeded chronological age by 8.8 and 2.3 years in the EUPD and control group, respectively. Similarly, EAA marker AgeAccelGrim was substantially higher in EUPD subjects when compared to controls, in both univariate and multivariate analyzes (p < 0.00001). Tobacco usage conferred substantial within-group effects on the EA-chronological age difference, i.e., 10.74 years (SD = 4.19) compared to 6.00 years (SD = 3.10) in the non-user EUPD group (p < 0.00001). Notably, past alcohol and substance abuse, use of psychotropic medications, global assessment of functioning, self-reported exposure to violent behavior in youth and adulthood, later completed suicide (N = 8) and age at first suicide attempt did not predict EAA in the EUPD group (p > 0.05). These results underscore the importance of addressing medical health conditions along with low-cost preventative interventions aimed at improving somatic health outcomes in EUPD, such as efforts to support cessation of tobacco use. The independency of GrimAge to other EA algorithms in this group of severely impaired EUPD patients, suggest it may have unique characteristics to evaluate risk of adverse health outcomes in context of psychiatric disorders.

Identifiants

pubmed: 36813766
doi: 10.1038/s41398-023-02369-7
pii: 10.1038/s41398-023-02369-7
pmc: PMC9946998
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

66

Informations de copyright

© 2023. The Author(s).

Références

J Psychiatr Res. 2021 May;137:131-146
pubmed: 33677217
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Curr Opin Psychiatry. 2012 Sep;25(5):398-404
pubmed: 22744403
Psychoneuroendocrinology. 2022 Jul;141:105765
pubmed: 35452872
Can J Psychiatry. 2017 May;62(5):336-342
pubmed: 28403655
J Clin Psychiatry. 2019 Jan 22;80(1):
pubmed: 30688417
Aging (Albany NY). 2019 Jan 21;11(2):303-327
pubmed: 30669119
Int J Mol Sci. 2020 Jan 28;21(3):
pubmed: 32012861
J Pers Disord. 2012 Oct;26(5):804-14
pubmed: 23013347
Am J Med Genet. 1999 Aug 20;88(4):430-6
pubmed: 10402513
Sci Rep. 2019 Dec 4;9(1):18290
pubmed: 31797972
JAMA Psychiatry. 2017 Jul 1;74(7):740-746
pubmed: 28538981
Psychiatry Res. 2018 Apr;262:70-77
pubmed: 29407572
Curr Psychiatry Rep. 2021 Apr 9;23(5):30
pubmed: 33835306
Psychoneuroendocrinology. 2019 Apr;102:149-157
pubmed: 30557762
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Psychiatry Res. 2018 Apr;262:311-315
pubmed: 29494867
Sci Rep. 2022 Mar 11;12(1):4277
pubmed: 35277542
Lancet Healthy Longev. 2021 Jun;2(6):e304-e305
pubmed: 36098139
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
Alcohol Clin Exp Res. 2022 May;46(5):736-748
pubmed: 35257385
Med Sci Sports Exerc. 2021 Mar 1;53(3):487-495
pubmed: 32868581
J Pers Disord. 2012 Aug;26(4):524-38
pubmed: 22867504
Transl Psychiatry. 2017 Aug 29;7(8):e1223
pubmed: 28850111
Harv Rev Psychiatry. 2016 Sep-Oct;24(5):311-29
pubmed: 27603741
Acta Psychiatr Scand. 2011 Nov;124(5):349-56
pubmed: 21564040
Psychoneuroendocrinology. 2022 Feb;136:105606
pubmed: 34896740
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Neurosci Biobehav Rev. 2019 Jan;96:316-334
pubmed: 30500331
Clin Epigenetics. 2020 Apr 5;12(1):52
pubmed: 32248841
Eur Respir J. 2022 Apr 21;59(4):
pubmed: 35086837
J Psychiatr Res. 2013 Oct;47(10):1499-506
pubmed: 23856083
Curr Opin Psychiatry. 2019 Sep;32(5):381-387
pubmed: 31145144
J Clin Psychiatry. 2008 Apr;69(4):533-45
pubmed: 18426259
Mol Psychiatry. 2021 Sep;26(9):4999-5009
pubmed: 32382136
Neuropsychopharmacology. 2006 Sep;31(9):1982-90
pubmed: 16495936
Neurosci Biobehav Rev. 2017 Feb;73:48-67
pubmed: 27988314
Acta Psychiatr Scand. 2018 Apr;137(4):287-295
pubmed: 29238963
Eur J Psychotraumatol. 2014 May 16;5:
pubmed: 24959326
Lancet. 2021 Oct 23;398(10310):1528-1540
pubmed: 34688371
Am J Psychiatry. 2004 Nov;161(11):2108-14
pubmed: 15514413
Acta Psychiatr Scand. 2020 Oct;142(4):319-325
pubmed: 32740913
Drug Alcohol Depend. 2022 Apr 1;233:109363
pubmed: 35231715
Lancet. 2011 Jan 1;377(9759):74-84
pubmed: 21195251
BMC Res Notes. 2019 Sep 16;12(1):583
pubmed: 31526398
Behav Res Ther. 1997 Jul;35(7):633-49
pubmed: 9193127
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Transl Psychiatry. 2020 May 4;10(1):129
pubmed: 32366819
Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):343-6
pubmed: 21762830
Psychol Rev. 2010 Apr;117(2):623-36
pubmed: 20438240

Auteurs

Adrian Desai E Boström (ADE)

Department of Clinical Sciences/Psychiatry, Umeå University, Umeå, Sweden. adrian.bostrom@umu.se.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, SE-171 76, Stockholm, Sweden. adrian.bostrom@umu.se.

Peter Andersson (P)

Department of Clinical Neuroscience/Psychology, Karolinska Institute, Stockholm, Sweden.
Centre for Clinical Research Dalarna, Uppsala University, Falun, Sweden.

Esmail Jamshidi (E)

Department of Clinical Sciences/Psychiatry, Umeå University, Umeå, Sweden.

Alexander Wilczek (A)

Department of Clinical Sciences, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden.

Åsa Nilsonne (Å)

Department of Clinical Sciences, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden.

Mathias Rask-Andersen (M)

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Marie Åsberg (M)

Department of Clinical Sciences, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden.

Jussi Jokinen (J)

Department of Clinical Sciences/Psychiatry, Umeå University, Umeå, Sweden.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH